InterMune Inc (NASDAQ:ITMN) VP Sean P. Nolan unloaded 2,644 shares of the company’s stock on the open market in a transaction dated Thursday, May 8th. The shares were sold at an average price of $35.85, for a total transaction of $94,787.40. Following the transaction, the vice president now directly owns 72,556 shares in the company, valued at approximately $2,601,133. InterMune Inc (NASDAQ:ITMN) weekly performance is 3.13%. On last trading day company shares ended up $36.23. Analysts mean target price for the company is $39.50. InterMune Inc (NASDAQ:ITMN) distance from 50-day simple moving average (SMA50) is 13.72%.
Illumina Inc (NASDAQ:ILMN) Director Daniel Bradbury sold 2,100 shares of Illumina stock in a transaction dated Friday, May 2nd. The shares were sold at an average price of $139.66, for a total transaction of $293,286.00. Following the sale, the director now directly owns 9,924 shares in the company, valued at approximately $1,385,986. Illumina, Inc. (NASDAQ:ILMN) shares advanced 3.42% in last trading session and ended the day on $148.23. ILMN Gross Margin is64.30% and its return on assets is 7.10%. Illumina, Inc. (NASDAQ:ILMN) quarterly performance is-8.35%.
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) EVP Henry J. Fuchs sold 3,479 shares of the company’s stock in a transaction that occurred on Friday, May 9th. The shares were sold at an average price of $57.91, for a total transaction of $201,468.89. Following the sale, the executive vice president now directly owns 67,850 shares of the company’s stock, valued at approximately $3,929,194. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) shares moved up 1.30% in last trading session and was closed at $59.30, while trading in range of $58.38 – $60.10. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) year to date (YTD) performance is -15.71%.
Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) Director Rick Winningham sold 27,500 shares of the company’s stock in a transaction that occurred on Tuesday, APRIL 17th. The shares were sold at an average price of $ 140.00, for a total transaction of $ 3,850,000.00. Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) ended the last trading day at $130.23. Company weekly volatility is calculated as 4.84% and price to cash ratio as 12.15. Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) showed a negative weekly performance of-8.28%.
Leave a Reply